Stay updated on Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial
Sign up to get notified when there's something new on the Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial page.

Latest updates to the Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial page
- Check3 days agoChange DetectedThe completed Phase 3 roxadustat study record is displayed, with details about its design, participant criteria, outcome measures, investigators, and 359 study locations. The page also includes publications and study documents.SummaryDifference100%

- Check10 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA notice about NIH’s terminology transition appears above the study page’s 403 error, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of rendering the study details, indicating access is blocked or the record cannot be loaded. This reflects a site access issue rather than changes to the study data.SummaryDifference16%

- Check59 days agoChange DetectedThe page's revision indicator was updated from v3.6.6 to v3.7.0, signaling a newer version of the document. This is a metadata-level change, not affecting the study content or user-facing details.SummaryDifference0.0%

Stay in the know with updates to Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial page.